Unilateral BEST1 -Associated Retinopathy

Wabbels, 2006, Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy, Graefes Arch Clin Exp Ophthalmol, 244, 1453, 10.1007/s00417-006-0286-6 Querques, 2009, Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene, Mol Vis, 15, 2960 Marmor, 2011, ISCEV standard for clinical electro-oculography (2010 update), Doc Ophthalmol, 122, 1, 10.1007/s10633-011-9259-0 McCulloch, 2015, ISCEV Standard for full-field clinical electroretinography (2015 update), Doc Ophthalmol, 130, 1, 10.1007/s10633-014-9473-7 Bach, 2013, ISCEV standard for clinical pattern electroretinography (PERG): 2012 update, Doc Ophthalmol, 126, 1, 10.1007/s10633-012-9353-y Marchant, 2007, New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy, J Med Genet, 44, e70, 10.1136/jmg.2006.044511 Marchant, 2001, Identification of novel VMD2 gene mutations in patients with best vitelliform macular dystrophy, Hum Mutat, 17, 235, 10.1002/humu.9 Sohn, 2009, Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy, Arch Ophthalmol, 127, 913, 10.1001/archophthalmol.2009.148 Boon, 2007, Clinical and genetic heterogeneity in multifocal vitelliform dystrophy, Arch Ophthalmol, 125, 1100, 10.1001/archopht.125.8.1100 Kramer, 2003, Ten novel mutations in VMD2 associated with Best macular dystrophy (BMD), Hum Mutat, 22, 418, 10.1002/humu.9189 Deutman, 1969, Electro-oculography in families with vitelliform dystrophy of the fovea. Detection of the carrier state, Arch Ophthalmol, 81, 305, 10.1001/archopht.1969.00990010307001 Francois, 1967, Electro-oculography in vitelliform degeneration of the macula, Arch Ophthalmol, 77, 726, 10.1001/archopht.1967.00980020728003 Weber, 1994, Molecular evidence for non-penetrance in Best's disease, J Med Genet, 31, 388, 10.1136/jmg.31.5.388 Marmorstein, 2007, Focus on molecules: bestrophin (best-1), Exp Eye Res, 85, 423, 10.1016/j.exer.2006.03.021 Renner, 2005, Late onset is common in best macular dystrophy associated with VMD2 gene mutations, Ophthalmology, 112, 586, 10.1016/j.ophtha.2004.10.041 Bakall, 1999, The mutation spectrum of the bestrophin protein–functional implications, Hum Genet, 104, 383, 10.1007/s004390050972 Lotery, 2000, Allelic variation in the VMD2 gene in best disease and age-related macular degeneration, Invest Ophthalmol Vis Sci, 41, 1291 Mullins, 2007, Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease, Invest Ophthalmol Vis Sci, 48, 3372, 10.1167/iovs.06-0868 Mullins, 2005, Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation, Arch Ophthalmol, 123, 1588, 10.1001/archopht.123.11.1588 Fung, 2015, New best1 mutations in autosomal recessive bestrophinopathy, Retina, 35, 773, 10.1097/IAE.0000000000000387 Kunzelmann, 2015, TMEM16, LRRC8A, bestrophin: chloride channels controlled by Ca(2+) and cell volume, Trends Biochem Sci, 40, 535, 10.1016/j.tibs.2015.07.005 Kane Dickson, 2014, Structure and insights into the function of a Ca(2+)-activated Cl(-) channel, Nature, 516, 213, 10.1038/nature13913 Boon, 2009, The spectrum of ocular phenotypes caused by mutations in the BEST1 gene, Prog Retin Eye Res, 28, 187, 10.1016/j.preteyeres.2009.04.002 Gomez, 2013, Role of bestrophin-1 in store-operated calcium entry in retinal pigment epithelium, Pflugers Arch, 465, 481, 10.1007/s00424-012-1181-0 Strauss, 2014, The role of bestrophin-1 in intracellular Ca(2+) signaling, Adv Exp Med Biol, 801, 113, 10.1007/978-1-4614-3209-8_15 Singh, 2013, iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration, Hum Mol Genet, 22, 593, 10.1093/hmg/dds469